NCT00240591View on ClinicalTrials.gov

Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Lymphoma, Non-Hodgkin
Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY